Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()

Breast cancer (BCa) molecular subtypes include luminal A, luminal B, normal-like, HER-2–enriched, and basal-like tumors, among which luminal B and basal-like cancers are highly aggressive. Biochemical pathways associated with patient survival or treatment response in these more aggressive subtypes a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Putluri, Nagireddy, Maity, Suman, Kommangani, Ramakrishna, Creighton, Chad J., Putluri, Vasanta, Chen, Fengju, Nanda, Sarmishta, Bhowmik, Salil Kumar, Terunuma, Atsushi, Dorsey, Tiffany, Nardone, Agostina, Fu, Xiaoyong, Shaw, Chad, Sarkar, Tapasree Roy, Schiff, Rachel, Lydon, John P., O’Malley, Bert W., Ambs, Stefan, Das, Gokul M., Michailidis, George, Sreekumar, Arun
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4198742/
https://ncbi.nlm.nih.gov/pubmed/25016594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.05.007
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items